Rosiglitazone is not associated with an increased risk of bladder cancer

Title
Rosiglitazone is not associated with an increased risk of bladder cancer
Authors
Keywords
-
Journal
Cancer Epidemiology
Volume 37, Issue 4, Pages 385-389
Publisher
Elsevier BV
Online
2013-04-23
DOI
10.1016/j.canep.2013.03.013

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More